AusBiotech is Australia's peak industry body for the biotechnology sector, representing over 3,000 members across life sciences, including therapeutics, medical technology (devices and diagnostics), digital health, and agritech. For over 30 years, it has been dedicated to promoting the global growth of the Australian biotechnology industry by facilitating commercialisation, advocating for supportive policies and regulations, and providing comprehensive services and networking opportunities to its members. AusBiotech plays a crucial role in connecting industry, research, and government to foster innovation and investment in this vital sector.
Serves as the central administrative and strategic hub for AusBiotech, coordinating national advocacy efforts, member services, event management, and policy development for Australia's biotechnology industry.
Located in a prominent Melbourne CBD premium-grade office tower, offering accessibility and a professional environment for stakeholders. The Collins Street address is synonymous with business and finance in Melbourne.
A collaborative, dynamic, and mission-driven environment focused on supporting and advancing the Australian biotech ecosystem. Emphasis on expertise, advocacy, member engagement, and fostering connections within the industry.
The Melbourne headquarters is central to AusBiotech's operations, strategically positioned in a key Australian city for biotechnology and research, enabling effective engagement with government, industry partners, and research institutions nationwide.
While primarily focused on Australia, AusBiotech actively promotes the Australian biotechnology sector on the global stage. This includes leading 'Team Australia' delegations to major international industry conferences (such as the BIO International Convention), fostering international partnerships, facilitating access to international markets and capital for its members, and attracting overseas investment into Australian biotech. They support Australian companies in navigating international regulatory landscapes and connecting with global peers, investors, and collaborators.
Level 4, 120 Collins Street
Melbourne
VIC
Australia
Address: The National Industry Innovation Network Hub, Cicada Innovations, Workshop B, National Innovation Centre, Australian Technology Park, 4 Cornwallis Street, Eveleigh NSW 2015
To support and connect with members in NSW, drive local initiatives, represent NSW biotech interests, and contribute to state-level policy discussions.
Address: Level 1, M Block, QEII Medical Centre, 11 Robin Warren Drive, Nedlands WA 6009
To foster the growth of the biotech sector in Western Australia, connect local members with national opportunities, advocate for regional needs, and support WA-based biotech enterprises.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, AusBiotech' leadership includes:
AusBiotech has been backed by several prominent investors over the years, including:
AusBiotech's core executive leadership team, including the CEO and COO, has demonstrated stability over the past 12 months (May 2023 - May 2024), with no publicly announced C-level staff hires or departures. This continuity supports the ongoing execution of strategic initiatives for the Australian biotechnology sector. Board director appointments and re-appointments typically occur annually following the AGM.
Discover the tools AusBiotech uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
AusBiotech primarily uses the email format of the first initial followed by the last name for its staff, utilizing the ausbiotech.org domain. General inquiries can be directed to admin@ausbiotech.org.
[firstinitial][lastname]@ausbiotech.org
Format
lchiroiu@ausbiotech.org
Example
90%
Success rate
AusBiotech Official Website • May 15, 2024
AusBiotech acknowledged some positive initiatives in the 2024-25 Federal Budget but highlighted missed opportunities for stronger strategic support for Australia's biotechnology sector. Key measures discussed include investments in research, skills, and manufacturing, alongside calls for more comprehensive long-term industry strategies....more
AusBiotech Official Website • May 9, 2024
AusBiotech, in collaboration with Johnson & Johnson Innovation, launched an industry position paper focused on advancing women in STEM. The paper outlines challenges and proposes actionable recommendations to improve gender equity and support female leadership in the biotechnology and STEM fields....more
AusBiotech Official Website • April 16, 2024
AusBiotech revealed the 'TeamAus 2024' delegation, a contingent of Australian biotechnology companies and organizations set to represent the nation's life sciences sector at the upcoming BIO International Convention in San Diego. This initiative aims to showcase Australian innovation and foster international collaborations....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including AusBiotech, are just a search away.